Search the Newsreel

Talen Energy (TLN) Stock May Already Be Priced Rich On Raised 2026 Guidance

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Talen Energy stock has delivered a very large return over the past three years, yet the broader valuation checks now flag a possible …

Booz Allen Hamilton Holding Corporation (NYSE:BAH) Plans Quarterly Dividend of $0.59

Lenskart Q1 profit jumps; Tata stocks tumble

Talen Energy: Very Solid FCF Yield, With More Upside If Data Center Pipeline Converts

TotalEnergies SE: Information Concerning the Total Number of Voting Rights and Shares in the Share Capital as at July 31, 2026

(Article L.233-8-II of the French Commercial Code and article 223-16 of the General Regulation of the AMF) PARIS, August 12, 2026--(BUSINESS WIRE)--Regulatory News: TotalEnergies SE (Paris:TTE) (LSE:TTE) (NYSE:TTE): Date Total number of shares Number of voting rights Theoretical (1) Exercisable (2) July 31, 2026 …

Why is LENZ Therapeutics stock rallying today?

Silence Therapeutics (SLN) Receives a Buy from Morgan Stanley

What's Going On With Dominion Lending Centres Inc Stock Wednesday?

Morgan Stanley Adjusts Agilent Technologies PT to $175 From $160, Maintains Overweight Rating

Morgan Stanley has increased its price target for Agilent Technologies (A) to $175, up from $160, while reiterating an Overweight rating on the stock. This adjustment reflects a positive outlook for the company's financial performance and market position.

Silence upsizes USD 175m offering after divesiran Phase II win

Silence Therapeutics plc announced an upsized public offering, raising $175 million to fund the Phase III development of its lead siRNA asset, divesiran. This follows positive Phase II data for divesiran in polycythemia vera, showing an 88% clinical response rate. The company also has …

Valens Semiconductor, Ltd. (VLN) Reports Q2 Loss, Beats Revenue Estimates

Valens Semiconductor, Ltd. (VLN) came out with a quarterly loss of $0.04 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.04 per share a year ago. These figures are adjusted for non-recurring items. A quarter ago, it …

Valens Semiconductor shares surge after company raises full-year guidance

Semiconductor ©Adobe Stock Images Valens Semiconductor Ltd. (NYSE:VLN) shares soared 16.07% in premarket trading on Wednesday after the connectivity chipset company raised its full-year 2026 outlook, overshadowing a marginal second-quarter revenue miss. The company reported an adjusted loss per share of $0.04, in line …

Why is Silence Therapeutics stock sliding today?

Lenskart Q1 Results: Profit zooms 182% YoY to Rs 228 crore; revenue up 34%

Valens Semiconductor Q2 2026 earnings: Higher revenue supports raised guidance

Valens Semiconductor reported a 6.1% increase in Q2 2026 revenue to $18.1 million, driven by cross-industry business and automotive growth, leading to a raised full-year 2026 revenue guidance. Despite this, GAAP net losses widened, operating cash outflows increased, and automotive gross margins contracted due …

Valens Semiconductor (VLN) shows H1 2026 loss but maintains solid cash reserves

Valens Semiconductor (VLN) reported a net loss of $16.342 million for the first half of 2026, consistent with the prior year, despite a slight revenue increase to $34.964 million. The company maintains a strong liquidity position with $42.557 million in cash and cash equivalents …

Valens Semiconductor stock soars 16% on raised guidance despite revenue miss

Valens Semiconductor Ltd. (NYSE:VLN) reported Q2 results, meeting earnings expectations but slightly missing revenue targets. Despite the revenue miss, the company's stock surged 16.07% in pre-market trading due to raised full-year 2026 revenue guidance, now projected to be between $78.0 million and $81.0 million, …

The Top 5 Analyst Questions From Oaktree Specialty Lending’s Q2 Earnings Call

Zacks Research Has Bearish Estimate for MRSH Q3 Earnings

Marsh & McLennan Companies, Inc. $MRSH Shares Acquired by Handelsbanken Fonder AB

Handelsbanken Fonder AB increased its stake in Marsh & McLennan Companies (NYSE:MRSH) by 7.4% in the second quarter, purchasing an additional 14,929 shares valued at $36 million. Marsh & McLennan recently reported strong quarterly earnings, exceeding analyst estimates, and raised its quarterly dividend. The …

TotalEnergies SE Sponsored ADR $TTE Shares Sold by Fulton Bank N.A.

Fulton Bank N.A. reduced its holdings in TotalEnergies SE Sponsored ADR (NYSE:TTE) by 31.9% in the second quarter, selling 16,870 shares and retaining 36,015 shares valued at $2.8 million. TotalEnergies reported quarterly earnings of $2.68 per share on $57.1 billion in revenue, with shares …

Is Marsh & McLennan Companies (MRSH) Undervalued On Its Accel Acquisition?

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Marsh & McLennan Companies (MRSH) is back in focus after its Marsh McLennan Agency unit agreed to acquire Accel Holdings, an Iowa based insurance and advisory firm, …

Royal Bank of Canada Sells 74,118 Shares of Booz Allen Hamilton Holding Corporation $BAH

Millennium & Copthorne Hotels New Zealand (NZSE:MCK) Stock Faces Sharp Valuation Disconnect

Investor seeks Ethan Allen take-over

An activist investor, Doug Bergeron of DBG Investments Inc., is attempting a takeover of Ethan Allen Interiors, a furniture company with significant operations in the Kingdom’s economy. Bergeron, who owns a 5% stake, is nominating six board members, arguing the company needs modernization to …

Assenagon Asset Management S.A. Reduces Stock Position in TotalEnergies SE Sponsored ADR $TTE

Assenagon Asset Management S.A. significantly reduced its stake in TotalEnergies SE Sponsored ADR (NYSE:TTE) by 57% in the second quarter, selling 110,168 shares and retaining 83,197 shares valued at approximately $6.47 million. Despite this reduction by one investor, other institutional investors increased their holdings, …

Amundi Sells 27,558 Shares of Cullen/Frost Bankers, Inc. $CFR

Amundi significantly reduced its stake in Cullen/Frost Bankers by selling 27,558 shares, retaining 2,956 shares valued at $405,000. Cullen/Frost Bankers reported strong quarterly earnings of $2.70 per share and revenue of $608.65 million, both exceeding analyst expectations. The company also declared a quarterly dividend …

Projeções de Resultados: Marsh & McLennan Ord Shs (MRSH) — LPA e Crescimento de Receita

LENZ Therapeutics, Inc. Stock 12‑Month Price Target Cut to $29.86, Implies 473% Upside

Analysts have revised the average 12-month price target for LENZ Therapeutics, Inc. (LENZ) stock down to $29.86 from $32, with individual forecasts ranging from $7 to $60 per share. Despite the cut, this new target still suggests a substantial 473% potential upside from its …

Valens Semiconductor Reports Strong Second Quarter 2026 Results and Raises Full-Year Revenue Guidance

Valens Semiconductor reported strong financial results for the second quarter of 2026, exceeding revenue guidance with $18.1 million and achieving a GAAP gross margin of 61.5%. The company also raised its full-year 2026 revenue guidance to between $78.0 million and $81.0 million, reflecting confidence …

Helen of Troy (NasdaqGS:HELE) Stock Forecast & Analyst Predictions

Helen of Troy (HELE) is forecast to grow earnings by 133.7% and revenue by 1.5% per annum. The company expects consolidated net sales of $1.759 billion to $1.831 billion and diluted EPS (GAAP) of $3.57 to $4.18 for fiscal year 2027. Despite recent stock …

Silence Therapeutics prices upsized $175M ADS offering at $13.50 each

* Silence Therapeutics (SLN [https://seekingalpha.com/symbol/SLN]) priced an upsized underwritten public offering of 12.96M ADSs at $13.50 each, raising ~$175M in gross proceeds. * The underwriters have a 30-day option to purchase up to an additional 1.94M ADSs at the offering price. * The offering …

Challenger Gold Director Boosts Equity Stake Through Fee-For-Shares Arrangement

Q1 results 2026: HAL to Lenskart among companies to declare Q1 results today; full list here

Is Now An Opportune Moment To Examine Helens International Holdings Company Limited (HKG:9869)?

Carlyle Secured Lending Earnings Call Signals Turnaround